Is Allogene Therapeutics, Inc. (ALLO) a Buy, Sell, or Hold?
Allogene Therapeutics, Inc.
NASDAQ:ALLO
$1.86 USD
$0.01 (0.54%)
- Volume
- 3.43M
- Average Volume
- 11.78M
- Market Capitalization
- $453.6M
- P/E Ratio
- -2.42
- Dividend Yield
- 0.00%
- Price Target
- $6.43
- Year High
- $4.46
- Year Low
- $0.98
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $9.65
CCURRENT INSTITUTIONAL OWNERSHIP PERCENTAGE
0.37%
Investors Holding
6
change: -207 | last: 213
Increased Positions
3
change: -130 | last: 133
Reduced Positions
1
change: -37 | last: 38
New Positions
2
change: -49 | last: 51
Sold Positions
203
change: 189 | last: 14
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -44.3848 | last: 0.4438
Total Invested
1.87M
ALLO Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $1.37 | 220.62M | $302.25M | $51.69M | $83.25M | $333.82M |
| 2024-12-31 | $2.13 | 194.81M | $414.95M | $75.22M | $90.76M | $430.49M |
| 2023-12-31 | $3.21 | 156.93M | $503.75M | $83.16M | $95.12M | $515.72M |
| 2022-12-31 | $6.29 | 143.15M | $900.39M | $61.9M | $101.12M | $939.61M |
| 2021-12-31 | $14.92 | 135.82M | $2.03B | $173.31M | $73.13M | $1.93B |
| 2020-12-31 | $25.24 | 120.37M | $3.04B | $183.35M | $53.78M | $2.91B |
| 2019-12-31 | $25.98 | 101.06M | $2.63B | $175.13M | $53.03M | $2.5B |
| 2018-12-31 | $26.93 | 89.69M | $2.42B | $721.35M | $34.46M | $1.73B |
| 2017-12-31 | $25.00 | 44.01M | $1.1B | $- | $- | $1.1B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2.44 | 240.29M | $586.31M | $30.31M | $81.05M | $637.05M |
| 2025-12-31 | $1.37 | 220.62M | $302.25M | $51.69M | $83.25M | $333.82M |
| 2025-09-30 | $1.24 | 222.04M | $275.33M | $37.82M | $85.14M | $322.65M |
| 2025-06-30 | $1.13 | 218.93M | $247.39M | $52.33M | $79.24M | $274.3M |
| 2025-03-31 | $1.46 | 215.36M | $314.42M | $42.46M | $81.29M | $353.26M |
| 2024-12-31 | $2.13 | 210.57M | $448.52M | $75.22M | $90.76M | $464.06M |
| 2024-09-30 | $2.80 | 209.19M | $585.73M | $51.24M | $85.14M | $619.63M |
| 2024-06-30 | $2.33 | 190.03M | $442.76M | $170.67M | $94.21M | $366.31M |
| 2024-03-31 | $4.38 | 169.13M | $740.78M | $51.04M | $95.85M | $785.59M |
| 2023-12-31 | $3.21 | 168.34M | $540.36M | $83.16M | $95.12M | $552.32M |
| 2023-09-30 | $3.17 | 167.65M | $531.45M | $69.25M | $96.68M | $558.88M |
| 2023-06-30 | $4.97 | 146.8M | $729.58M | $154.76M | $91.82M | $666.64M |